scispace - formally typeset
Journal ArticleDOI

Impact of the Acidic C-Terminal Region Comprising Amino Acids 109−140 on α-Synuclein Aggregation in Vitro†

Wolfgang Hoyer, +3 more
- 26 Nov 2004 - 
- Vol. 43, Iss: 51, pp 16233-16242
TLDR
The effects of the C-terminus on aggregation cannot be rationalized merely by a contribution to the protein net charge, but rather suggest a specific role of aa109-140 in the regulation of aggregation, presumably involving formation of intramolecular contacts.
Abstract
The aggregation of alpha-synuclein, involved in the pathogenesis of several neurodegenerative disorders such as Parkinson's disease, is enhanced in vitro by biogenic polyamines binding to the highly charged C-terminal region aa109-140. In this study, we investigated the influence of this region on the aggregation kinetics, monitored by thioflavin T binding and static light scattering, and morphology, assessed by electron microscopy, fluorescence microscopy, and turbidity, by comparing the effect of various solution conditions on the wild-type protein, the disease related mutants A53T and A30P, and two truncated variants, syn(1-108) and syn(1-124), lacking the complete or the C-terminal half of the polyamine binding site. In the presence of the intact C-terminus, aggregation was strongly retarded in physiological buffer. This inhibition of aggregation was overridden by (i) addition of spermine or MgCl(2) or lowering of pH, leading to strong charge shielding in the C-terminus or (ii) by truncation of aa125-140 or aa109-140. Addition of MgCl(2) or spermine or acidification were not effective in promoting aggregation of syn(1-108). The impact of the disease-related mutations on the aggregation kinetics was dependent on the solution conditions, with the aggregation propensity order A53T approximately wt > A30P at low ionic strength, but A53T > wt approximately A30P at high ionic strength, with exceedingly potent promotion of aggregation by the A53T mutation in the presence of spermine. In contrast to full-length alpha-synuclein aggregates, those formed from syn(1-108) did not exhibit a pronounced polymorphism. The effects of the C-terminus on aggregation cannot be rationalized merely by a contribution to the protein net charge, but rather suggest a specific role of aa109-140 in the regulation of aggregation, presumably involving formation of intramolecular contacts.

read more

Citations
More filters
Journal ArticleDOI

Alpha-Synuclein in Parkinson’s Disease: From Pathogenetic Dysfunction to Potential Clinical Application

TL;DR: This review summarizes the current knowledge of the pathogenetic dysfunction of α-synuclein associated with Parkinson's disease and highlights current approaches that seek to develop this protein as a possible diagnostic biomarker and therapeutic target.
Journal ArticleDOI

Systematic Mutagenesis of α-Synuclein Reveals Distinct Sequence Requirements for Physiological and Pathological Activities

TL;DR: The data show that the physiological function ofα-synuclein, although protective of neurodegeneration in some contexts, is fundamentally distinct from its neuropathological effects, thereby dissociating the two activities of α- synuclein.
Journal ArticleDOI

Bacterial in-cell NMR of human α-synuclein: a disordered monomer by nature?

TL;DR: In-cell NMR evidence obtained directly in intact Escherichia coli cells is provided that challenges a tetrameric conformation under native in vivo conditions and indicates clearly that inside E. coli α-synuclein is mostly monomeric and disordered.
Journal ArticleDOI

The AAA-ATPase VPS4 Regulates Extracellular Secretion and Lysosomal Targeting of α-Synuclein

TL;DR: It is demonstrated that α-synuclein (αSYN), a principal culprit for Lewy pathology in Parkinson's disease (PD), was present in endosomal compartments and detectably secreted into the extracellular milieu, and VPS4, a master regulator of MVB sorting, may serve as a determinant of lysosomal targeting or extacellular secretion of αSYN and thereby contribute to the intercellular propagation of LewY pathology in PD.
Journal ArticleDOI

Alpha-synuclein targets the plasma membrane via the secretory pathway and induces toxicity in yeast.

TL;DR: A link between plasma membrane targeting of α-synuclein and its toxicity in yeast is revealed and a role for the quality control (QC) system is suggested in the cell's effort to deal with this natively unfolded protein.
References
More filters
Journal ArticleDOI

Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease.

TL;DR: It is demonstrated that at higher concentrations, Lewy body-like fibrils and discrete spherical assemblies are formed; most rapidly by A53T, suggesting mutation-induced acceleration of α-synuclein fibril formation may contribute to the early onset of familial PD.
Journal ArticleDOI

Fibrils Formed in Vitro from α-Synuclein and Two Mutant Forms Linked to Parkinson's Disease are Typical Amyloid†

TL;DR: Fibrils generated in vitro from alpha-synuclein, wild-type and both mutant forms, are shown to possess very similar features that are characteristic of amyloid fibrils, including a wound and predominantly unbranched morphology, distinctive dye-binding properties, and antiparallel beta-sheet structure.
Related Papers (5)